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Intrinsic lipid binding activity of ATG16L1 supports
efficient membrane anchoring and autophagy
Leo J Dudley1,†, Ainara G Cabodevilla1,†, Agata N Makar1 , Martin Sztacho2, Tim Michelberger1,
Joseph A Marsh3, Douglas R Houston4, Sascha Martens2 , Xuejun Jiang5 & Noor Gammoh1,*
Abstract
Membrane targeting of autophagy-related complexes is an impor-
tant step that regulates their activities and prevents their aberrant
engagement on non-autophagic membranes. ATG16L1 is a core
autophagy protein implicated at distinct phases of autophagosome
biogenesis. In this study, we dissected the recruitment of ATG16L1
to the pre-autophagosomal structure (PAS) and showed that it
requires sequences within its coiled-coil domain (CCD) dispensable
for homodimerisation. Structural and mutational analyses identi-
fied conserved residues within the CCD of ATG16L1 that mediate
direct binding to phosphoinositides, including phosphatidylinositol
3-phosphate (PI3P). Mutating putative lipid binding residues abro-
gated the localisation of ATG16L1 to the PAS and inhibited LC3 lipi-
dation. On the other hand, enhancing lipid binding of ATG16L1 by
mutating negatively charged residues adjacent to the lipid binding
motif also resulted in autophagy inhibition, suggesting that regu-
lated recruitment of ATG16L1 to the PAS is required for its auto-
phagic activity. Overall, our findings indicate that ATG16L1
harbours an intrinsic ability to bind lipids that plays an essential
role during LC3 lipidation and autophagosome maturation.
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Introduction
While some organelles, such as the endoplasmic reticulum (ER) or
mitochondria, are generated by growing and budding from pre-
existing organelles, autophagosome formation is initiated through
the de novo nucleation of membranous structures (Joshi et al,
2017). This process requires the activity of distinct protein
complexes that act to relay upstream signals in order to facilitate
the growth of precursor membranes known as pre-autophago-
somal structures (PAS; Lamb et al, 2013). Of these protein
complexes, the ATG5 complex, comprised of the ATG12~ATG5
conjugate and ATG16L1, plays a pivotal role in both the nucle-
ation of the PAS and the downstream conjugation of the ATG8
ubiquitin-like family of proteins (such as LC3) to phos-
phatidylethanolamine (PE; Sakoh-Nakatogawa et al, 2013). The
conjugation of LC3 on the PAS facilitates the maturation of
autophagosomes and the recruitment of cargo molecules for their
subsequent lysosomal degradation.
In order to better understand how autophagy-related complexes
are activated and recruited to the growing PAS, recent studies have
started to uncover the genetic and temporal hierarchy of these
complexes in mammalian cells (Itakura & Mizushima, 2010;
Koyama-Honda et al, 2013). Following inhibition of mTORC1 (e.g.
by amino acid starvation or small molecule inhibitors), the ULK1
complex is relieved from its inhibitory phosphorylation by mTOR,
resulting in its recruitment to the PAS independently of downstream
autophagy complexes (Itakura & Mizushima, 2010). The ULK1
kinase can phosphorylate and activate members of the ATG14
complex, containing the class III PI3K kinase Vps34, which facili-
tates the recruitment of phosphatidylinositol 3-phosphate (PI3P)
sensors (such as DFCP1, WIPI1 and WIPI2; Axe et al, 2008;
Matsunaga et al, 2010). FIP200, a component of the ULK1 complex,
and WIPI2b can both directly interact with ATG16L1, providing a
mechanism for the localisation of the ATG5 complex to the PAS
during mTORC1 inactivation (Gammoh et al, 2013; Nishimura et al,
2013; Dooley et al, 2014).
Membrane recruitment of most autophagy complexes is pivotal
for their role in autophagy. Ectopic recruitment to the plasma
membrane of an ATG5-binding fragment of ATG16L1 results in
aberrant and constitutive lipidation of LC3 (Fujita et al, 2008). Simi-
lar results were also obtained upon plasma membrane tethering of
the ATG16L1 binding partner, WIPI2b (Dooley et al, 2014). These
findings suggest that membrane localisation of ATG16L1 in cells is
sufficient to drive the conjugation of LC3 to PE and that its
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regulation could provide means to fine-tune autophagy. Despite the
above proposed hierarchy, it remains unknown how autophagy
players are recruited during ULK1-independent autophagy
(Gammoh et al, 2013). Furthermore, live-cell imaging analyses
suggest that both the recruitment and displacement of autophagy
proteins to the PAS occurs in an asynchronous manner, indicating
that protein–protein interactions are not sufficient to stabilise auto-
phagy complexes on membranes (Koyama-Honda et al, 2013). In
addition, sequences that correspond to WIPI2b and FIP200 binding
sites in mammalian ATG16L1 are absent in yeast Atg16 (Fujioka
et al, 2010; Gammoh et al, 2013; Nishimura et al, 2013; Dooley
et al, 2014). These observations suggest the existence of previously
unknown mechanisms that can mediate the localisation of the ATG5
complex to membranes.
Given the central role of the ATG5 complex during various forms
of LC3 conjugation, including both canonical and non-canonical
autophagy (Fletcher et al, 2018), we aimed to investigate how the
ATG5 complex is recruited to autophagy-related membranes. In this
study, we have identified highly conserved sequences within the
coiled-coil domain (CCD) of ATG16L1 that mediate its direct interac-
tion with lipids, thereby enhancing its PAS localisation and auto-
phagic activity.
Results
ATG16L1 membrane targeting activity is retained in the absence
of ATG5 or WIPI2
To investigate the membrane recruitment of the ATG5 complex, we
first addressed the role of either ATG5 or ATG16L1 in PAS target-
ing. Since deletion of either protein can destabilise the other
(Fig 1A, Nishimura et al, 2013), we generated knockout cell lines
stably expressing GFP-tagged proteins to avoid any discrepancies
resulting from reduction in protein levels or ectopic localisation (Li
et al, 2017). As seen in Fig 1B, the recruitment of stably expressed
ATG16L1 to punctate structures was not disrupted in the absence
of ATG5. On the other hand, ATG5 showed a diffused pattern of
staining in the absence of ATG16L1. Biochemical fractionation
further confirmed the finding that ATG16L1 accumulates in
membrane fractions in the absence of ATG5 (Fig 1C), as well as in
the absence of ATG3 (Gammoh et al, 2013). These results suggest
a role for ATG16L1 in the membrane targeting of the ATG5
complex. Previous studies show that the PAS localisation of an
ATG16L1 mutant lacking both WIPI2b and FIP200 binding
(ATG16L1ΔFBD) was markedly reduced but not completely inhib-
ited, suggesting that these interaction partners may act as signalling
players that enhance the membrane recruitment of ATG16L1
(Gammoh et al, 2013; Nishimura et al, 2013). This was further
confirmed in WIPI2/ cells where ATG16L1 puncta formation was
reduced but not fully inhibited (Fig 1D and E). Residual ATG16L1-
positive puncta formed in WIPI2/ cells were sensitive to Vps34
inhibition by 3-methyladenine (30MA) treatment, in agreement with
previous data showing the requirement of PI3P for the PAS recruit-
ment of the ATG5 complex (Koyama-Honda et al, 2013). Overall,
these findings suggest the existence of additional previously unde-
scribed mechanisms that mediate the recruitment of ATG16L1 to
the PAS.
PAS targeting activity of ATG16L1 lies within its CCD
To identify the region within ATG16L1 required for its localisation
to the PAS, we examined ATG16L1 puncta formation in U2OS cells
expressing a series of ATG16L1 truncation mutants (depicted in
Fig 2A). As seen in Fig 2B, the deletion of N-terminal sequences
containing the ATG5 binding (fragment Δ1, residues 39–623) or
the further downstream linker region (fragment Δ2, residues 120–
623) did not affect puncta formation when compared to wild-type
ATG16L1 (ATG16L1WT). On the other hand, subsequent fragments
lacking the CCD of ATG16L1 (fragments Δ3 and Δ4, residues 206–
623 and 336–623, respectively) were diffused in cells, suggesting
that PAS targeting requires either the dimerisation of ATG16L1 or
additional unknown activities within the CCD. To distinguish these
two possibilities, we aimed to further delete sequences within the
CCD that were predicted to be dispensable for dimerisation. Based
on ATG16L1 structural predictions and comparisons to yeast Atg16
(Fujioka et al, 2010), we analysed conserved regions within the
ATG16L1 CCD that were predicted to not contribute to the dimer-
dimer interface. A combined deletion of amino acids 182–205
within the context of the Δ2 fragment (ATG16L1Δ2Δ182–205) resulted
in a diffused pattern of staining, indicating the requirement of
these residues of ATG16L1 for puncta formation (Fig 2C). We
further confirmed that deleting residues 182–205 within the
context of the full-length protein (ATG16L1Δ182–205) did not inter-
fere with the ability of ATG16L1 to interact with FIP200 and ATG5
or homodimerise (Fig 2D and E), whereas a truncation mutant
lacking the CCD, but not the WD40 domain, was unable to
homodimerise (Fig 2F). When expressed in ATG5/ cells, the
deletion mutant, ATG16L1Δ182–205, exhibited a diffused pattern of
staining (Fig 2G), whereas ATG16L1WT formed punctate structures.
These findings confirm that sequences within the CCD are required
for PAS targeting but dispensable for previously identified func-
tions of ATG16L1, including dimerisation and binding to FIP200
and ATG5.
ATG16L1 binds liposomes through CCD sequences
Having shown that the localisation of ATG16L1 to punctate struc-
tures requires sequences within its CCD of unknown function, we
further investigated the relevance of these sequences in recruiting
ATG16L1 to the PAS. Further analyses of the CCD domain region
indicated the presence of a hydrophobic region and positively
charged residues that could mediate direct lipid binding of ATG16L1
to membranes (Fig 3A). To address this possibility, we used a
microscopy-based technique to test the recruitment of rhodamine-
labelled small unilamellar vesicles (SUVs) to beads coated with
ATG16L1-GFP (Fracchiolla et al, 2016), a sensitive approach to
detect protein-lipid binding activities. As seen in Fig 3B and C, there
was no significant recruitment of liposomes to ATG16L1-GFP-bound
beads when using liposome preparations that contained phos-
phatidylinositol (PI), phosphatidylethanolamine (PE), phosphatidyl-
choline (PC) and phosphatidylserine (PS) suggesting an inability of
ATG16L1 to bind these phospholipids. Consistent with the hypothe-
sis that ATG16L1 can directly bind to autophagy-related
membranes, liposome recruitment to ATG16L1-GFP beads was
enhanced when incubated with PI3P-containing liposomes, an
essential lipid for the biogenesis of autophagosomes (Axe et al,
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2008). Moreover, liposome preparations containing phosphatidyli-
nositol 4-phosphate (PI4P) or phosphatidylinositol 4,5-bisphosphate
(PI(4,5)P2) also resulted in enhanced recruitment to ATG16L1-GFP
containing beads, indicating that these membrane phospholipids
can also bind ATG16L1. The binding of ATG16L1 to liposomes was
independent of ATG5 or its WD40 domain as a deletion mutant of
ATG16L1 lacking its C-terminal half was able to bind liposomes
when purified from ATG5/ cells (Fig EV1A and B). We further
confirmed the ability of wild-type ATG16L1 to bind PI3P in an inde-
pendent assay using lipid-coated beads, where we also detected its
binding to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2)
(Fig EV1C). In contrast, ATG16L1 did not significantly bind to phos-
phatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3) when compared to
control beads, suggesting a degree of specificity for phosphoinosi-
tides. Interestingly, this assay also revealed that ATG16L1 has low
binding affinity for PE and PS, while also exhibiting an affinity for
PA, although this was found to be non-significant compared to the
control beads.
The ability of ATG16L1 to bind PI3P suggests that positively
charged residues, potentially located within or juxtaposed to amino
acids 182–205 of its CCD, may mediate this interaction. Although
previous studies have identified interactions between coiled-coil
domains and phospholipids (Horikoshi et al, 2011; Zheng et al,
2014), the structural bases underlying these have not yet been
directly elucidated. To explore the potential structural mechanism of
ATG16L1-lipid interaction, we performed structural prediction anal-
yses of a short region of mouse ATG16L1 CCD and modelled its
interaction with PI3P embedded in a lipid bilayer. These analyses
predict that ATG16L1 CCD could potentially interact with the nega-
tively charged headgroup of PI3P by lying flat on the membrane
surface (Fig 3D). Molecular dynamics simulation of the protein in
association with PI3P in a model lipid bilayer indicated that this
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Figure 1. ATG16L1 membrane targeting activity is retained in the absence of ATG5 or WIPI2.
A Analyses of protein expression in lysates of various cell lines by Western blotting against the indicated antibodies.
B Fluorescence analyses of GFP-ATG5 or ATG16L1-GFP stably expressed in ATG5/ or ATG16L1/. Cells were amino acid starved for 2 h prior to fixation and imaging of
the GFP fluorescence. Scale bar: 10 lm.
C Assessment of ATG16L1 levels in the cytosolic (C) and membrane (M) fractions in lysates of the indicated cell lines using Western blot analyses and antibodies against
ATG16L1. ATG16L1/ and ATG5/ stably expressed ATG16L1-GFP while ATG3/ stably expressed Flag-S-ATG16L1. Antibodies against a-tubulin and integrin b1 were
used as controls for fractionation. Exogenous (exo) ATG16L1 was detected using antibodies against ATG16L1.
D Lack of WIPI2 expression is confirmed by Western blot analyses in wild-type MEFs (WIPI2+/+) and WIPI2/ cells.
E Immunofluorescence analyses of ATG16L1/ and WIPI2/ stably expressing Flag-S-ATG16L1. Cells were amino acid starved (AA starve) for 2 h in the presence or
absence of 30MA (and additional pretreatment for 30 min) followed by fixation and immunostaining using antibodies against Flag tag to detect ATG16L1. Scale bar:
9 lm. Right panel represents quantification of three independent experiments and error bars depicting SEM values. *P ≤ 0.05, **P ≤ 0.01 (pairwise unpaired
Student’s t-test).
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association was stable over the course of the trajectory. Interest-
ingly, helices and coiled-coil domains have also been previously
shown to interact with lipid bilayers by lying flat on the membrane
surface, although adopting a different mechanism than that
predicted for ATG16L1 (utilising primarily hydrophobic rather than
electrostatic interactions; Pluhackova et al, 2015; Woo & Lee, 2016).
Our homology modelling highlights three residues, including K179,
R193 and the further upstream residue I171, which line the outer
faces of the coiled-coil and are solvent-exposed, thereby free to
interact with the phosphate groups of PI3P or PI(3,4)P2. These resi-
dues are conserved in yeast Atg16 but are missing from ATG16L2, a
protein closely related to ATG16L1 that does not localise to the PAS
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Figure 2. PAS targeting activity of ATG16L1 lies within its CCD.
A Schematic presentation of ATG16L1 fragments and mutants used in this study. The following fragments encompassed the indicated amino acids: wild type (WT): 1–
623; Δ1: 39–632; Δ2: 120–623; Δ3: 206–623 and Δ4: 336–623. Mutant Δ2Δ182–205 consists of the Δ2 fragment with an additional deletion in amino acids 182–205. All
constructs contained a Flag-S tag at the N-terminal end.
B Fragments depicted in (A) were expressed in U2OS cells and amino acid starved for 5 h followed by fixation and immunostaining against S tag to detect S-ATG16L1.
Scale bar: 10 lm.
C U2OS cells expressing Flag-ATG16L1Δ2 or Flag-ATG16L1Δ2Δ182–205 were treated as in (B) and stained using antibodies against Flag tag (to detect ATG16L1, green) and
FIP200 (red). Scale bar: 10 lm.
D Protein–protein interaction assay in 293T cells transiently transfected with the indicated Flag-S-tagged ATG16L1 constructs. S tag pull-down was performed and
protein complexes were analysed by immunoblotting using the indicated antibodies.
E Homodimerisation assay in 293T cells transiently transfected with ATG16L1-GFP and the indicated Flag-S-tagged ATG16L1 constructs. S tag pull-down was performed
and protein complexes were analysed by immunoblotting using the indicated antibodies.
F Homodimerisation assay similar to (E).
G Flag-ATG16L1WT or Flag-ATG16L1Δ182–205 were stably expressed in ATG5/ cells and analysed by immunofluorescence using antibodies against Flag tag to detect
ATG16L1. Scale bar: 9 lm.
4 of 16 The EMBO Journal e100554 | 2019 ª 2019 The Authors
The EMBO Journal Leo J Dudley et al
Published online: April 1, 2019 
Atg16 Sc: 099LNDELISGTIENNVLQQKLSDLKKEHSQLVARWLKKTEKETEAMNSEIDGTK150 
ATG16L1 Xt:  162LKDEYDALQITFTALEDKLRKTTEDNQELVSRWMAEKAQEANRLNAENEKDSKRRQARLQKELAEAAKEPLSFEHDDDIEVLNDNADP249 
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Figure 3. ATG16L1 binds liposomes through CCD sequences.
A Sequence alignment of ATG16L1 CCD segment from various species and ATG16L2 (Sc: Saccharomyces cerevisiae; Xt: Xenopus (Silurana) tropicalis; Hs: Homo sapiens; Mm:
Mus musculus). Residues that mediate WIPI2b and FIP200 binding are highlighted in orange and magenta, respectively. Cyan-shaded residues (I171, K179 and R193) are
exposed conserved residues predicted to not contribute to the dimer-dimer interface and are mutated in this study. Cherry-shaded residues are mutated in Figs 6 and 7.
B Microscopy-based protein-liposome binding assay. ATG16L1-GFP immobilised on beads incubated in the presence of rhodamine-labelled liposome preparations
containing the indicated phosphoinositides. Scale bar: 50 lm.
C Quantification of relative liposome binding in (B).
D Structural modelling of ATG16L1 residues 160–205 (magenta helix) in the presence of lipid bilayer (green lines). Highlighted residues include I171, K179 and R193 as
sticks, which are mutated in this study. A PI3P molecule is shown as a yellow stick embedded in the lipid bilayer and interacting with the highlighted positively
charged residues of ATG16L1.
E Microscopy-based protein–liposome binding assay as in (B). ATG16L1WT- and ATG16L1LD-GFP immobilised on beads were incubated with rhodamine-labelled, PI3P-
positive liposome preparations. Scale bar: 50 lm. Right panel shows quantification of liposome binding relative to ATG16L1WT from three independent experiments
including SEM values.
F Protein–protein interaction assay in 293T cells transiently transfected with the indicated S-tagged ATG16L1 constructs. S tag pull-down was performed and protein
complexes were analysed by immunoblotting using the indicated antibodies.
G Dimerisation assay in 293T cells transiently transfected with ATG16L1-GFP and the indicated S-tagged ATG16L1 constructs and analysed as in (F).
Data information: Quantifications depict means and error bars (SEM) from at least three independent experiments. *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001 (pairwise
unpaired Student’s t-test).
ª 2019 The Authors The EMBO Journal e100554 | 2019 5 of 16
Leo J Dudley et al The EMBO Journal
Published online: April 1, 2019 
despite its ability to bind ATG5 and homodimerise (Ishibashi et al,
2011). As predicted, mutation of these three residues in ATG16L1 to
aspartic acid (I171D, K179D and R193D) strongly reduced the
recruitment of liposomes to ATG16L1-coated beads (Fig 3E). Hence,
we named this mutant ATG16L1LD for lipid binding-deficient
ATG16L1 mutant. Given that these residues are adjacent to WIPI2b
and FIP200 binding sites, we further confirmed that ATG16L1LD did
not interfere with the ability of ATG16L1 to bind these two interac-
tors nor interfere with ATG16L1 homodimer formation (Fig 3F and
G). Overall, these data suggest that ATG16L1 contains residues
within its CCD that mediate interactions to negatively charged lipids
but are dispensable for its dimerisation and binding to WIPI2 and
FIP200.
Binding of ATG16L1 to lipids is required for PAS recruitment
To dissect the functional relevance of ATG16L1 lipid binding in
cells, we further analysed the localisation of ATG16L1WT and
ATG16L1LD, stably expressed in ATG16L1/ cells. When compared
to ATG16L1WT, we observed a strong inhibition of ATG16L1LD
recruitment to puncta positive for ATG5 and WIPI2 during amino
acid starvation (Fig 4A and B), suggesting that ATG16L1 lipid bind-
ing is required for its efficient recruitment to the PAS. Additionally,
the overall intensity of ATG16L1LD puncta was significantly reduced
compared to that of ATG16L1WT, implying that ATG16L1 is
recruited less efficiently to these sites (Fig 4C). Furthermore,
enhanced formation of WIPI2-positive puncta, as observed by recon-
stituting ATG16L1/ cells with ATG16L1WT, was impaired in
ATG16L1LD-expressing cells, indicating that ATG16L1 lipid binding
may influence early autophagic events (Fig 4B). Residual
ATG16L1LD punctate structures could potentially be due to its ability
to bind upstream autophagy players, including WIPI2b and FIP200,
which have been proposed to facilitate its recruitment to the PAS
(Gammoh et al, 2013; Nishimura et al, 2013; Dooley et al, 2014).
To test this possibility, we stably expressed ATG16L1LD in WIPI2/
cells and observed a further reduction in puncta formation of this
mutant to levels comparable to background levels in mock infected
cells (Fig 4D). Overall, these data suggest that the efficient recruit-
ment of ATG16L1 to the PAS relies on its ability to interact with
both PI3P through CCD sequences and protein binding partners,
such as WIPI2b.
Binding of ATG16L1 to lipids is required for autophagy
To examine the functional impact of disrupted PAS localisation in
the lipid binding-deficient mutant, ATG16L1LD, we further assessed
its ability to mediate LC3 lipidation in cells. When compared to
ATG16L1/ cells reconstituted with ATG16L1WT, ATG16L1LD-
expressing cells exhibited a strong inhibition of LC3 lipidation
during amino acid starvation (Fig 5A). To confirm that autophagy
was inhibited, we measured the levels of p62, an adaptor protein
that is degraded during autophagy, following amino acid starvation.
Consistent with the LC3 lipidation results, p62 degradation was
impaired in ATG16L1LD-expressing cells, suggesting that autophagic
flux was also inhibited (Fig 5A). Furthermore, we tested LC3 lipida-
tion induced by carbonyl cyanide m-chlorophenylhydrazone (CCCP,
10 lM) treatment, shown to induce the selective degradation of
mitochondria (Narendra et al, 2008), and similarly observed
defective LC3 lipidation in ATG16L1LD-expressing cells (Fig 5B).
Similar results were obtained during autophagy induced by glucose
starvation, suggesting that the lipid binding domain of ATG16L1 is
also required for autophagy induced in the absence of mTORC1
inhibition and ULK1-complex activation (Fig 5C). Given that non-
canonical LC3 lipidation can occur on single membranes and
requires the ATG5 complex but not additional upstream autophagy
machinery, such as WIPI2 or the ULK1 complex, we further exam-
ined whether ATG16L1LD could support LC3 lipidation during
treatment with monensin, ammonium chloride (NH4Cl) or CCCP
(100 lM), known to act as ionophores and/or lysosomotropic agents
(Jacquin et al, 2017). Consistent with previous results, these treat-
ments required the activity of ATG16L1WT to support LC3 lipidation
(Fig 5D and E; Fletcher et al, 2018), whereas LC3 lipidation was
strongly diminished in ATG16L1LD-expressing cells. Collectively,
these data suggest that the lipid binding activity of ATG16L1 is
required to facilitate both LC3 lipidation induced by various stimuli
and the efficient degradation of autophagic cargo.
In addition to binding FIP200 and WIPI2b, ATG16L1 has also
been shown to bind Rab33B through sequences within its middle
region (Itoh et al, 2008). The relevance of Rab33B binding remains
to be further explored as published studies suggest that shRNA-
mediated inhibition of Rab33B expression did not affect LC3 lipida-
tion while overexpression of a GTP-hydrolysis-deficient (constitu-
tively active) mutant of Rab33B enhanced LC3 lipidation (Itoh et al,
2008, 2011). We further tested whether mutating lipid binding resi-
dues within the CCD of ATG16L1 affected the interaction between
ATG16L1 and Rab33B. Surprisingly, ATG16L1LD exhibited a
strongly diminished affinity to GFP-Rab33B compared to
ATG16L1WT (Fig EV2A). To assess whether genetic inhibition of
Rab33B influenced autophagy in a manner that mimicked mutating
the residues involved in ATG16L1 lipid binding, we generated
Rab33B/ cells using CRISPR/Cas9-mediated gene editing in MEF
cells. Rab33B/ cells did not exhibit reduced LC3 lipidation
(Fig EV2B) or disrupt ATG16L1 puncta formation (Fig EV2C) in a
manner that resembled ATG16L1LD-reconstituted cells (Figs 4A and
5A). Altogether, these data suggest that the functional relevance of
ATG16L1 binding to Rab33B is distinct from its binding to PI3P
(Ishibashi et al, 2011; Fujita et al, 2013).
Negatively charged residues within the CCD of ATG16L1 weakens
its interaction to lipids
The above studies indicate that the lipid binding ability of
ATG16L1 is required for its membrane recruitment and subsequent
LC3 lipidation. Because the ATG5 complex, along with upstream
autophagy complexes, are only transiently recruited to the
autophagosome (Karanasios et al, 2013; Koyama-Honda et al,
2013), we aimed to examine the implication of persistent localisa-
tion of ATG16L1 to the PAS. Our structural analyses predicted that
multiple negatively charged residues that are exposed on the same
heptad repeat positions as residues I171, K179 and R193 (Fig 6A)
are likely to be involved in the binding of the CCD to lipids on the
membrane surface due to their close proximity to the lipid bilayer.
Mutating these negatively charged residues (namely D164, E165,
E178, E185 or E186) is likely to enhance the affinity of ATG16L1
for lipids. To test this, we mutated two conserved adjacent resi-
dues, D164 and E165 (highlighted in Fig 3A), to alanine (D164A
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Figure 4. Binding of ATG16L1 to lipids is required for PAS recruitment.
A ATG16L1/ stably expressing the indicated Flag-S-ATG16L1 constructs were amino acid starved for 2 h prior to immunofluorescence analyses using antibodies
against Flag tag (green) and ATG5 (red). Scale bar: 9 lm. Right panels show quantifications of average number of Flag- and ATG5-positive dots per cell.
B Cells, as in (A), were immunostained using antibodies against S tag (to detect ATG16L1, red) and WIPI2 (green). Scale bar: 9 lm. Lower panel shows quantification of
average number of WIPI2-positive dots per cell.
C Average intensities of individual Flag-ATG16L1 dots in (A). Underlying grey circles represent individual data points. Dots were quantified (n = 1,225 for ATG16L1WT;
n = 334 for ATG16L1LD).
D WIPI2/ cells reconstituted with the indicated Flag-S-ATG16L1 constructs were amino acid starved for 2 h prior to immunofluorescence analyses using antibodies
against Flag tag (green) and FIP200 (red). Scale bar: 9 lm. Lower panel shows quantification of average number of Flag-positive dots per cell.
Data information: Quantifications depict means and error bars (SEM) from at least three independent experiments. *P ≤ 0.05, ***P ≤ 0.001, ****P ≤ 0.0001 (pairwise
unpaired Student’s t-test).
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and E165A) and termed the resulting mutant ATG16L1LE for its
potentially lipid binding-enhancing ability. Furthermore, mutating
residues D164 and E165 retained the ability of ATG16L1 to bind
Rab33B (Fig EV3A). To test lipid binding activity, we generated
recombinant ATG16L1 protein spanning residues 72–307, which
lacks both the ATG5 binding domain and the C-terminal WD40
domain, in order to enhance protein expression as shown previ-
ously (Fig 5B, Archna & Scrima, 2017). We next tested the lipid
binding activity of the ATG16L1LE mutant using liposome co-sedi-
mentation assays and SUVs prepared by sonication. Similar to
previously published data (Romanov et al, 2012), we observed a
weak interaction between ATG16L1WT and liposomes under these
conditions (Fig 6C). Importantly, this fragment of ATG16L1
(ATG16L172–307
WT) was able to bind liposomes in the imaging-
based experiment, suggesting that its weak pelleting in the lipo-
some co-sedimentation assay is not due to the lack of ATG5 bind-
ing or WD40 domains but due to differences in the experimental
approach (Fig EV3B). Interestingly, ATG16L1LE exhibited enhanced
liposome binding, suggesting that residues D164 and E165 can
modulate the affinity of ATG16L1 for lipids (Fig 6C). Similar to
ATG16L1WT protein tested using the GFP-coated beads setting
(Fig 3B), the enhanced liposome binding ability of ATG16L1LE was
also dependent on PI3P (Fig 6D). Importantly, mutations in resi-
dues D164 and E165 and lipid binding residues (I171, K179 and
R193) in the combined mutant ATG16L1LELD (D164A, E165A,
I171D, R179D and K193D) abolished the lipid binding activity of
ATG16L1 (Fig 6C), suggesting that ATG16L1LE enhances the lipid
binding activity of CCD residues. In the context of our model
(Fig 3D), we conclude that the loss of negative charges on the
exposed surface of this CCD region enhances the affinity of
ATG16L1 for negatively charged lipid headgroups, such as PI3P.
Persistent localisation of ATG16L1 to PAS inhibits autophagy
To assess the consequence of persistent lipid binding in cells, we
tested the recruitment of ATG16L1LE to the PAS. When
ATG16L1WT and ATG16L1LE were expressed in ATG16L1/ cells,
similar numbers of cells were positive for ATG16L1 puncta follow-
ing amino acid starvation (Fig 7A and C). Furthermore, these
puncta showed comparable colocalisation with WIPI2 (Fig 7A).
Importantly, puncta formed by ATG16L1LE were sensitive to Vps34
inhibition by 30MA treatment suggesting the relevance of PI3P in
its PAS localisation (Fig 7B and C). Interestingly, ATG16L1LE loca-
lised to PAS structures that were positive for WIPI2 and responsive
to Vps34 inhibition under unstarved conditions or upon replenish-
ment with full growth media following amino acid starvation
(Figs 7D and EV4A–C). Importantly, these observations indicate
that ATG16L1LE persistently localises to autophagic structures. To
test whether persistent localisation of ATG16L1 to the PAS resulted
in enhanced or deleterious effects on autophagy, we tested LC3
lipidation in ATG16L1/ cells expressing either ATG16L1WT or
ATG16L1LE. As can be seen in Fig 7E, LC3 lipidation was signifi-
cantly inhibited in ATG16L1LE-expressing cells. Punctate structures
formed by ATG16L1LE under unstarved conditions could be due to
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Figure 5. Binding of ATG16L1 to lipids is required for autophagy.
ATG16L1/ cells were reconstituted with ATG16L1WT- or ATG16L1LD-expression constructs and autophagy assessed during treatment with various stimuli followed by
immunoblotting using the indicated antibodies.
A Cells were amino acid starved (AA starve) to induce mTORC1-dependent autophagy in the presence or absence of BafA1 for 2 h prior to lysis.
B Mitophagy was induced by CCCP (10 lM) treatment for 6 h prior to lysis.
C Glucose starvation (Glu starve) for 20 h was used to induce mTORC1-independent autophagy. BafA1 was added to all conditions 2 h prior to lysis.
D LC3-associated phagocytosis (LAP)-like LC3 lipidation was induced by treating cells with CCCP (100 lM) for 2 h prior to lysis. Right panel shows quantification of LC3-
II/LC3-I ratio. Means and error bars (SEM) are shown (n = 4). **P ≤ 0.01 (pairwise unpaired Student’s t-test).
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inhibited phagophore maturation which has been shown to accu-
mulate the ATG5 complex on the PAS (Sou et al, 2008; Gammoh
et al, 2013). To test whether ATG16L1LE affects autophagy in cells
that contain endogenous ATG16L1, we expressed ATG16L1
constructs in WIPI2/ cells where autophagic vesicle formation is
impaired but not fully inhibited (Bakula et al, 2017). Expression of
ATG16L1LE, but not ATG16L1WT, resulted in inhibited LC3 lipida-
tion in a dominant negative manner, thereby suggesting that
enhanced lipid binding can have deleterious effects on phagophore
maturation during both basal and amino acid starvation-induced
autophagy (Fig 7F). We did not observe similar inhibition of LC3
lipidation upon ATG16L1LE expression in wild-type MEFs (data not
shown). Since wild-type ATG16L1 puncta formation was markedly
reduced in WIPI2/ cells (Fig 1E), the dominant negative effects
of ATG16L1LE are likely to require higher expression levels in the
context of wild-type cells in order to compete with endogenous
ATG16L1WT. Overall, these results suggest that regulated localisa-
tion of ATG16L1 to the PAS is required for autophagy.
Binding of ATG16L1 to lipids is required for ferroptosis
Ferroptosis is a recently described cell death mechanism dependent
on iron availability (Gao et al, 2015) and the induction of autophagy
(Gao et al, 2016). Metabolic stress induced by amino acid starvation
in the presence of serum has been shown to induce ferroptosis
which can be suppressed by the genetic inhibition of autophagy or
use of dialysed serum to deplete glutamine. To test whether the lipid
binding mutants of ATG16L1 can mediate the role of autophagy in
supporting ferroptosis, we cultured cells in amino acid free media in
the presence of 10% FBS (to induce ferroptosis) or 10% dialysed
FBS (diFBS, as a control). As previously shown, cell death measured
by propidium iodide (PI) staining was robustly induced in
ATG16L1/ cells stably expressing ATG16L1WT compared to
parental ATG16L1/ cells in conditions that induce ferroptosis
(Figs 7G, and EV4D and E). Importantly, cell death was strongly
inhibited in cells expressing ATG16L1LD or ATG16L1LE, emphasising
the important role of regulated ATG16L1-lipid binding for auto-
phagy and its functional activities.
Discussion
Our study shows for the first time that ATG16L1 harbours an
intrinsic ability to bind autophagy-related membranes through
direct interaction with PI3P. This interaction requires conserved
sequences within the CCD of ATG16L1 that, when mutated, result
in inhibited recruitment to the PAS and LC3 lipidation. Impor-
tantly, enhancing lipid binding of ATG16L1 by mutating negatively
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charged residues also disrupted LC3 lipidation, suggesting that the
tightly regulated recruitment of ATG16L1 to the PAS is important
to permit the proper maturation of the phagophore. This is
reflected by the weak lipid binding activity of ATG16L1 in the
liposome co-sedimentation assay, which indicates that additional
factors, such as interactions with other autophagy complexes and/
or post-translational modifications on ATG16L1, may enhance its
recruitment to the PAS in cells.
Given that inhibiting the catalysis of PI3P impairs autophagy
(Blommaart et al, 1997), the PI3P dependency of ATG16L1 lipid
binding implies its role in directly binding to sites of autophagosome
biogenesis. It remains unclear whether the affinity of ATG16L1 for
PI3P or other phosphoinositide species provides a mechanism for its
targeting to additional membrane compartments including the
plasma membrane and endocytic vesicles (Ravikumar et al, 2010;
Puri et al, 2013). Interestingly, a recent study shows that the recruit-
ment of WIPI2- to PI3P-positive recycling endosomes requires both
its lipid and protein interactions with PI3P and RAB11A, respec-
tively (Puri et al, 2018). In a parallel mechanism, the recruitment of
ATG16L1 to the PAS, as well as other membrane compartments,
could require both lipid and protein interactions. Furthermore,
ATG16L1-dependent lipidation of LC3 on single membranes, for
example during treatment with ionophores and lysosomotropic
agents, has been shown to occur independently of FIP200, WIPI2
and PI3P (Florey et al, 2015; Fletcher et al, 2018). The ability of
ATG16L1 to bind other phosphoinositides as well as potentially
unidentified protein interactors may be required to mediate the role
of ATG16L1 during non-canonical LC3 lipidation. Additionally,
potential binding of ATG16L1 to other phospholipids, such as PA,
may be required for unknown functions of ATG16L1 that are inde-
pendent of PAS recruitment.
The middle region of ATG16L1 has also been shown to bind
Rab33B with the specific residues that mediate this interaction not
previously identified (Itoh et al, 2008; Ishibashi et al, 2011). Intrigu-
ingly, we find that mutating residues I171D, K179D and R193D in
the lipid-deficient mutant, ATG16L1LD, strongly reduced its binding
to Rab33B. It is therefore possible that the proper recruitment of
ATG16L1 to the PAS, mediated through its lipid binding, is required
for Rab33B binding. It is also possible that the binding of the CCD of
ATG16L1 to lipids and Rab33B occur in a mutually exclusive
manner, thereby regulating the function of ATG16L1 during various
stages of autophagy. Indeed, previous work has shown that a
RabGAP for Rab33B, OATL1, can influence the autophagosome–
lysosome fusion, thereby suggesting that Rab33B may also act at
later stages of autophagosome maturation (Itoh et al, 2011). Future
studies addressing these questions will help further understand the
regulation of ATG16L1 activities.
There are discrepancies regarding the proposed hierarchies in
which autophagy players are recruited to the growing autophago-
some (Koyama-Honda et al, 2013; Dooley et al, 2014). The recruit-
ment of these complexes could occur independently of each other
given the individual intrinsic membrane-binding abilities of the
ULK1 complex (Karanasios et al, 2013), WIPI proteins (Baskaran
et al, 2012), and ATG5 complex (this study). However, the effi-
ciency of their recruitment appears to be interdependent. For
instance, ATG16L1 and WIPI2 puncta are reduced in WIPI2/ and
ATG16L1/ cells, respectively (this study and Dooley et al, 2014).
Furthermore, multiple ATG-related proteins can recognise PI3P at
the phagophore, many of which harbour non-canonical PI3P bind-
ing motifs (including WIPI2b and ATG16L1). The question remains
as to whether these PI3P effectors can simultaneously bind to PI3P
or whether their binding occurs consecutively. If the latter is true,
this may represent a mechanism whereby the ATGs can regulate the
recruitment and displacement of one another.
Consistent with our findings using the lipid binding-enhanced
mutant ATG16L1LE, membrane tethering of an N-terminal half of
ATG16L1 disrupted LC3 lipidation in cells in a manner dependent
on CCD sequences (Park et al, 2016). It remains to be addressed
how persistent localisation of ATG16L1 to the PAS can inhibit
downstream lipidation of LC3. These inhibitory effects suggest that
the displacement of ATG16L1, and potentially upstream autophagy
machinery, is required for autophagosome growth. The mechanism
through which this occurs remains to be elucidated. It is possible
that the overall growth and curvature of the autophagosome may
induce the release of autophagy players. Alternatively, it is also
possible that additional factors, for instance local changes in
calcium levels at the ER (Engedal et al, 2013) or post-translational
modifications, may aid in neutralising acidic residues located on the
lipid-exposed face of the CCD (including D164, E165, E178, E185 or
E186). Such regulatory modifications may enhance the electrostatic
interactions with the negatively charged lipids and modulate
ATG16L1 PAS recruitment. Our data suggest that such fine-tuning of
this localisation is essential for proper maturation of autophago-
somes.
◀ Figure 7. Persistent localisation of ATG16L1 to PAS inhibits autophagy.ATG16L1/ cells were reconstituted with ATG16L1WT- or ATG16L1LE-expression constructs and autophagy assessed during amino acid starvation (AA starve) followed by
immunoblotting or immunofluorescence analyses.
A Immunofluorescence analyses of amino acid starved cells (2 h) using antibodies against WIPI2 (red) or ATG16L1 (green). Scale bar: 9 lm.
B Cells as in (A) with the addition of 30MA (and pretreatment with the drug for 30 min). Scale bar: 9 lm.
C Quantification of percentage of cells positive for ATG16L1 puncta in (A) and (B).
D Cells were left untreated, amino acid starved for 2 h or amino acid starved for 2 h followed by refeeding with full growth media for 1 h. Puncta formation was
assessed by immunofluorescence staining using antibodies against S tag to detect ATG16L1. Scale bar: 10 lm.
E Immunoblot analyses of amino acid starved cells in the presence or absence of BafA1 for 2 h. Cell lysates were analysed using the indicated antibodies.
F WIPI2/ cells reconstituted with the indicated ATG16L1 constructs were amino acid starved for 2 h. BafA1 treatment was included in all conditions for 2 h prior to
lysis. Cell lysates were analysed by immunoblotting using the indicated antibodies. Quantification of LC3-II/LC3-I ratio of three independent experiments is shown on
the right panel.
G Ferroptosis assay in ATG16L1/ cells stably expressing ATG16L1WT, ATG16L1LD or ATG16L1LE. Cells were cultured in amino acid free media in the presence of 10% FBS
or 10% dialysed FBS (diFBS) for 24 h. Quantification of percentage of PI-positive cells from at least three independent experiments is shown.
Data information: Quantifications depict means and error bars (SEM) from at least three independent experiments. ns P > 0.05, *P ≤ 0.05, **P ≤ 0.01 (pairwise unpaired
Student’s t-test).
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Materials and Methods
Cell culture
Wild-type mouse embryonic fibroblasts (MEFs), ATG3 knockout
MEFs (/, kind gift from Dr Masaaki Komatsu), ATG16L1/,
ATG5/ (kind gift from Dr Noboru Mizushima), WIPI2/, U2OS
and 293T cells were cultured in DMEM supplemented with 10% FBS,
L-glutamine (2 mM), penicillin (10 units/ml) and streptomycin
(0.1 mg/ml). Stable overexpression of GFP-LC3, GFP-ATG or F-S-ATG
proteins was obtained by retroviral infection using pBabe expression
plasmids followed by blasticidin or puromycin selection. For transient
expression, lipofectamine 2000 (Invitrogen) was used according to the
manufacturer’s instructions. WIPI2, ATG16L1 and Rab33B knockout
cells were generated by CRISPR/Cas9-mediated gene editing in wild-
type MEFs and transiently expressing Cas9 and gRNA constructs
followed by single clone selection for deleted lines. The following
gRNA sequences were used to target WIPI2 or ATG16L1: 50 GCTCTA
CATACACAACATC or 50 AAAGCATGACATGCCAAAT, respectively.
For Rab33B knockout, a combination of the following gRNA
sequences was used: 50 GACTTCCGAGAGCGAGCCG, 50 CGCTCTCCA
TCAATATCCA and 50 ACCGCACCGAGGCCACGAT.
Antibodies, reagents and treatments
The following antibodies were used: anti-LC3 (Sigma, #L7543); anti-
Actin (Sigma, #A5316); anti-p62/SQSTM1 (Cell Signalling, #5114);
anti-ATG16L1 (MBL, #PM040); anti-a-tubulin (Calbiochem, #CP06);
anti-S tag (Bethyl Laboratories, A190-135A); anti-ATG5 (Sigma,
#A0731); anti-FIP200 (Abcam, #ab176816); anti-T7 tag HRP
(Novagen); anti-FLAG (Sigma, M2); anti-b-integrin (Cell Signalling,
#4706); WIPI2 (Bio-Rad, 2A2); anti-ATG3 (MBL, M133-3); anti-
Rab33B (Rab33bd5-Mo-Tk02, Frontier Institute co.); anti-Rabbit
(CST, 7074); anti-Mouse (CST, 7076).
Bafilomycin A1 (BafA1, inhibitor of lysosome acidification) was
purchased from Sigma or Tocris and used at a final concentration of
20 nM. The following reagents were obtained from Sigma and used
at the indicated concentrations: monensin (M5273, 100 lM), ammo-
nium chloride (NH4Cl, A4514, 5 mM), carbonyl cyanide m-chloro-
phenylhydrazone (CCCP, C2759, 10 or 100 lM) or 3-methyladenine
(30MA, M9281, 5 mM).
For amino acid starvation experiments, cells were grown in DMEM
lacking amino acids and serum typically for 2 h prior to harvesting in
the presence or absence of BafA1. Glucose starvation was performed
by culturing cells in DMEM lacking glucose and sodium pyruvate,
supplemented with 10% dialysed FBS and glutamine (2 mM) for
20 h. BafA1 treatment was added 2 h prior to harvesting, as indi-
cated. Control cells were also grown in 10% dialysed FBS and gluta-
mine but in the presence of glucose and sodium pyruvate. For LAP-
like assays, cells were treated with monensin, NH4Cl or CCCP typi-
cally for 2 h prior to harvesting. For mitophagy assays, cells were
treated with CCCP typically for 6 h prior to harvesting.
Plasmids
Flag-S-tagged (F-S-) mouse ATG16L1 (NM_001205391.1) and mutants
were cloned into pBabe-F-S- retroviral vectors. ATG16L1 full-length
and truncation fragments (Δ1–Δ4 and ΔWD40) were previously
described (Gammoh et al, 2013). ATG16L1 mutants were obtained by
two-step PCR. Mutant Δ2Δ182-205 was generated using the following
forward primer: 50 AAGGAGCTTGCAGAAGCAGCAATTGTGGATGA
GACCTCA. To generated ATG16L1LD (I171D K179D R193D), consecu-
tive mutations of each residue were performed using the following
forward primers: I171D 50 TATGACGCCCTGCAGGACACTTTTA
CTGCCCTAGAAGAG; K179D 50 GAAGAGGACCTGAGGAAAACTA
CTGAG; R193D 50 GAACTGGTCACCGACTGGATGGCTGAG. For
ATG16L1LE, the following forward primer was used: 50 AACCA
GACCCTGAAGGCTGCGTATGACGCCCTGCAG. The second PCR step
of the above mutants was performed using the following common
forward and reverse primers: 50 GCAGCAGTCGACATGTCGTCGGGC
CTGCGCGC and 50 GCAGCACAATTGTCAAGGCTGTGCCCACAGCAC,
respectively. The final PCR products were cloned into pBabe-F-S-
using SalI and MfeI sites. C-terminal tagged ATG16L1WT-GFP was
previously described (Gammoh et al, 2013). ATG16L1LD-GFP was
subcloned from pBabe-F-S- vector using XhoI and EcoRI sites within
ATG16L1 sequences. ATG16L1ΔWD40-GFP was cloned by PCR using
MfeI and SalI sites and pBabe-F-S-ATG16L1ΔWD40 as a template. For
recombinant protein expression, ATG16L1 fragments spanning resi-
dues 72–307 were cloned into pET28a plasmid using the pBabe-F-S-
ATG16L1WT or pBabe-F-S-ATG16L1LD as templates and the following
forward and reverse primers: 50 GCAGCACAATTGGGACATGAT
GGTGCGTGGAAT and 50 CCGAAGTCGACTCAATCTTTACCAGAAGC
AGGATG, respectively. For protein purification from insect cells, wild-
type ATG16L1 was cloned by PCR into a pFastBac plasmid containing
His-Flag tags and using SalI and XhoI restriction sites and the follow-
ing forward and reverse primers: 50 GCAGCAGTCGACATGTC
GTCGGGCCTGCGCGC and 50 GCAGCAGTCGACTCAAGGCTGTGCC
CACAGCAC, respectively. GFP-Rab33B was generated by PCR amplifi-
cation of human Rab33B cDNA (BC036064.1) and cloning into pBabe-
GFP vector using SalI and EcoRI restriction sites and the following
forward and reverse primers 50 GCAGCAGTCGACATGGCTGAGGAG
ATGGAGTCG and 50 GCAGCAGAATTCTTAGCACCAGCACGTCAT
TGC, respectively.
Cell lysis, fractionation and Western blotting
For whole cell lysis, cells were washed twice with ice-cold PBS
followed by direct scraping in cell lysis buffer (10 mM Tris pH 7.5,
100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.1% SDS, 1% Triton X-
100, 1 mM b-ME, 0.5% sodium deoxycholate and 10% glycerol)
supplemented with protease inhibitor cocktail V (Fisher Scientific
UK). Lysates were cleared by spinning at 20,000 g for 10 min at
4°C. Cytosolic and membrane fractions were obtained by sequential
incubation in a detergent-free buffer (150 mM NaCl, 25 mM HEPES
pH 7.5 and 1.5 mM b-ME) supplemented with digitonin and NP-40,
respectively. Lysates were analysed by SDS–PAGE and transferred
onto nitrocellulose membranes or in the case of LC3 blotting to
PVDF membranes (Bio-Rad). Membranes were blocked in 5% milk-
TBST for 30 min or overnight followed by immunoblotting with the
indicated antibodies. Membranes were developed under UV light
using ClarityTM Western ECL substrate (Bio-Rad, 1705061).
Pull-down assays
Cell lysates were obtained from 293T cells grown in 10-cm plates
and transfected with the indicated plasmids by direct lysing in
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NP-40 buffer (150 mM NaCl, 25 mM HEPES pH 7.5, 1.5 mM MgCl₂,
1 mM EDTA, 1.5 mM b-ME and 0.5% NP-40) supplemented with
protease inhibitor cocktail V (Fisher Scientific UK) and proteasome
inhibitor MG132 (Sigma). Cell lysates were cleared by spinning at
20,000 g for 10 min at 4°C and incubated with S-protein agarose
(Novagen) for 5 h or overnight at 4°C. Beads were then washed 3
times with NP-40 buffer, and bound proteins were analysed by
SDS–PAGE and Western blotting.
Recombinant proteins purification
T7-His-tagged ATG16L172–307 and mutants were expressed from
pET28a plasmid in Escherichia coli strain BL21 (DE3, Novagen) and
grown overnight at 37°C in 50 ml of lysogeny broth (LB) media,
containing 50 lg/ml kanamycin. After the initial incubation, the cell
culture was diluted into 800 ml LB media with the selection agent
and incubated at 37°C until OD600 reached 0.8. To overexpress the
protein, host cells were then induced by 0.3 mM IPTG (Sigma) and
the culture was maintained for 5 h at 37°C. The cells were centri-
fuged at 3,830 g for 5 min, supernatant discarded and pellets stored
at 80°C. Cell lysis was performed as previously described (Archna
& Scrima, 2017). Briefly, cell pellets were resuspended in 20 ml
buffer containing 50 mM HEPES pH 7.0, 5% glycerol, 300 mM
NaCl, 5 mM-mercaptoethanol (b-ME), 5 mM MgCl2, 5 lg DNase
(Roche) and 5 mg lysozyme (Sigma) per litre of culture. Resus-
pended cells were homogenised using a syringe-based homogenisa-
tion method in the presence of 1 mM phenylmethylsulphonyl
fluoride (PMSF), and the cell lysate was centrifuged for 30 min at
21,130 g. Cell lysate supernatant was applied on an equilibrated
1 ml Ni-NTA resin (Novagen) column. Following loading of the
lysate, the column was washed to remove unbounded proteins
using 50 ml of buffer (20 mM Tris pH 7.5 300 mM NaCl, 2 mM b-
ME, 20 mM imidazole). Protein elution was performed using
increasing concentrations of imidazole, ranging from 20 to 250 mM,
and collected as 1 ml fractions. Eluted fractions were dialysed for
2 h in buffer containing 150 mM NaCl, 50 mM HEPES pH 7.5 and
1 mM DTT.
Purification of wild-type ATG16L1 from insect cells was
performed by the MRC Protein Phosphorylation and Ubiquitylation
Unit Reagents and Services, Dundee—UK. Of note, this protein was
not used in the liposome co-sedimentation assay as it was prone to
pelleting in the absence of liposomes at high centrifugation speeds.
Microscopy
For fluorescence analyses, cells were grown on glass coverslips in a
6-well plate. 24 h later, cells were either left untreated or treated as
indicated. Coverslips were then fixed with 3.7% paraformaldehyde
in 20 mM HEPES pH 7.5 for 30 min at room temperature followed
by permeabilisation in 0.1% Triton X-100 in PBS for 5 min or cells
were fixed and permeabilised by incubating with 20°C methanol
on ice for 5 min. Slides were then incubated in primary antibodies
in blocking buffer (PBS supplemented with 1% BSA) at 37°C for 2–
3 h followed by incubation with Alexa Fluor secondary antibodies
(Invitrogen) for 30 min at room temperature. DAPI (Sigma, D9542)
was then used to stain nucleic acids. Following extensive washes,
coverslips were mounted on microscope slides and images were
acquired using a Leica SP5 microscope.
Liposome preparation and co-sedimentation assay
All lipids were purchased from Avanti unless otherwise indicated.
Small unilamellar vesicles (SUVs) were prepared by drying chloro-
form-dissolved lipids under nitrogen air followed by desiccation
under vacuum for 0.5 h. A buffer containing 150 mM NaCl, 50 mM
HEPES pH 7.5 and 1 mM DTT was added to rehydrate the dried
lipid layer and produce a final lipid concentration of 1 mg/ml.
Following 30-min incubation, liposomes were either sonicated in a
water bath for 5–10 min or extruded using 100-nm filters and Avanti
mini extruder.
For liposome co-sedimentation assays, 50 ng of His-T7-tagged
recombinant ATG16L1 was mixed with 30 ll of 1 mg/ml liposomes
(35% DOPC, 35% DOPS, 25% DOPE, 5% PI3P) along with BSA to a
final concentration 0.5 mg/ml and incubated for 30 min at room
temperature. Samples were then transferred to Thickman
Polypropylene tubes (Beckman Coulter, 347287) containing lipo-
some binding buffer to yield a final volume of 500 ll and ultracen-
trifuged for 10 min at 180,000 g and 22°C (Optima Max Beckman
Coulter Ultracentrifuge, TLA 120.2 rotor). Equal proportions of the
pellet and supernatant were analysed by SDS–PAGE and Western
blotting using anti-T7-HRP antibodies.
Microscopy-based protein–liposome interaction assay
For Fig 3B, Hap1 cells were grown in suspension at 37°C in a 3 l
Wheaton spinner flask for 5 days, harvested by centrifugation at
1,300 g for 15 min at 4°C and washed three times with PBS.
Pellets were flash-frozen in liquid nitrogen, resuspended in ice-
cold liposome binding buffer (150 mM NaCl, 50 mM Tris pH 7.5,
1 mM DTT supplemented with complete protease inhibitors
EDTA-free cocktail, Roche Diagnostics) and cleared by centrifuga-
tion with 13,000 g at 4°C for 15 min. For purification of
ATG16L1, 50 ll of StrepTactin Sepharose High performance beads
(GE Healthcare) was added to 4 mg total protein in the super-
natant and incubated for 2 h at 4°C. Beads were washed four
times with liposome binding buffer. For microscopy-based
protein–liposome interaction assay (Fracchiolla et al, 2016), 1 ll
of StrepTactin beads covered with ATG16L1 was incubated with
15 ll of liposomes (1 mg/ml) prepared by extrusion (100 nm)
and contained the following composition 39.5% DOPC, 35%
DOPS, 20% DOPE, 5% phosphoinositides (as indicated in the fig-
ure) and 0.5% rhodamine-phosphoethanolamine (L1392, Thermo
scientific). The binding reaction was incubated for 15 min at
room temperature.
For Figs 3E and EV1A, mouse ATG16L1-GFP and mutants were
expressed by transient transfection in 293T cells. 24–48 h later, cells
were lysed in cell lysis buffer (as above) and subjected to pull down
using GFP-Trap beads (Chromotek) for 2 h at 4°C. Beads were then
washed three times in lysis buffer followed by three washes in lipo-
some binding buffer (150 mM NaCl, 50 mM Tris pH 7.5, 1 mM
DTT). For Fig EV3B, 15 ng of T7-His-tagged ATG16L172–307
WT was
incubated with Ni-NTA resin for 1 h at 4°C. Beads were then
washed 3 times in liposome binding buffer. Beads were then mixed
with 1 ll of 1 mg/ml extruded liposomes containing 35% DOPC,
35% DOPS, 23% DOPE, 5% PI3P and 2% rhodamine-DOPE as well
as 0.25 mg/ml BSA in a final volume of 40 ll and incubated at room
temperature for 10 min.
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All samples were imaged immediately by loading onto a 96 glass
bottom plate and using a confocal microscope equipped with a 20×
objective. Relative liposome binding to beads was quantified in
ImageJ by taking maximum brightness along a straight line drawn
on the beads and subtracting the values to adjacent empty regions
of the image (background fluorescence). Liposome binding of
ATG16L1LD in Fig 3E was normalised to the GFP signal of
ATG16L1WT.
Lipid beads binding assay
The following lipid beads were purchased from Echelon Bios-
ciences: PI3P beads (P-B003a), PI(3,4)P2 beads (P-B034a), PI
(3,4,5)P3 beads (P-B345a), phosphatidylserine beads (PS, P-B0PS),
phosphatidic acid beads (PA, P-B0PA), phosphatidylethanolamine
beads (PE, P-B0PE) and PIP control beads (P-B000). For pull-down
assays, 20 ng of recombinant wild-type ATG16L1 purified from
insect cells was incubated with 5 ll beads and 0.1 mg/ml BSA
diluted in liposome binding buffer supplemented with 0.5% Igepal.
After 1-h incubation at 4°C with rotation, beads were washed three
times in Igepal-supplemented liposome binding buffer and bound
protein was eluted in SDS loading buffer and analysed by Western
blotting.
Structural modelling
The i-TASSER webserver (Zhang, 2008) was used to thread the
sequence of mouse ATG16L1 onto the structure of the Saccha-
romyces cerevisiae Atg16 (PDB code 3A7P). This produced a helical
monomer. PyMol (The PyMOL Molecular Graphics System, Version
2.0 Schro¨dinger, LLC.) was used to create a coiled-coil dimer by
aligning to the yeast structure. A NAMD topology of the dimer was
generated using the psfgen plugin of VMD 1.9.3 (Humphrey et al,
1996). To generate the lipid bilayer model, the Membrane plugin
of VMD was used to build a rectangular matrix of PI3P embedded
in phosphatidylcholine onto which the dimer was orientated. The
VMD script combine.tcl was used to merge the protein and
membrane models and remove sterically clashing lipids. It was
then solvated and neutralised by the addition of TIP3P water mole-
cules (Jorgensen et al, 1983) and Na+ and Cl ions (to a concen-
tration of 150 mM) to form a 125.1 A˚ × 123.7 A˚ × 87.4 A˚
simulation box. The full system comprised 123,533 atoms. NAMD
2.12 (Phillips et al, 2005) was used for simulating this system, util-
ising the CHARMM36 force field (Huang et al, 2017) in a Langevin
temperature and pressure controlled (NPT @ 310K) ensemble with
periodic boundary conditions and particle-mesh Ewald electrostat-
ics. Following 10,000 energy minimisation steps (2 fs/step) to
remove van der Waals clashes within the system, a production run
of 10 ns was performed. The Ca RMSD of residues 164–198
between starting structure and final frame of the simulation was
2.05 A˚, indicating that protein association with lipid was stable
over this timeframe.
Ferroptosis assay
Induction of ferroptotic cell death was performed as previously
described (Gao et al, 2015). Briefly, ATG16L1/ cells stably
expressing F-S-ATG16L1 constructs were seeded in a 12-well dish
for 24 h followed by treatment in DMEM lacking amino acids and
supplemented with 10% FBS (to induce ferroptosis) or 10% dial-
ysed FBS (diFBS) as a control. 24 h later, cells were stained with
propidium iodide (PI) and imaged using a Leica DM IL LED micro-
scope.
Graphs and statistical analyses
Graph-making and statistical analyses were performed on Prism 7
(GraphPad). All quantifications were performed on a minimum of
three independent experiments. Statistical significance was
measured by performing unpaired Student’s t-tests on no more
than two data sets per analysis. Quantifications of immunofluores-
cence dot numbers and intensities were conducted in ImageJ. For
the latter, a suitable threshold was set in ImageJ and the “Analyze
particles” feature was used to record the mean grey values of dots.
LC3-II/LC3-I ratio densitometry analysis was performed in
ImageLab.
Expanded View for this article is available online.
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